Coming Soon: Dried Plasma for Hemorrhagic Trauma in the Prehospital Setting
It is now well-established that prehospital transfusion of plasma, with its balanced mix of coagulation proteins, counters the hemodilution and progressive derangement of hemostatic mechanisms caused by crystalloid-based resuscitation, improving the changes of survival in severely bleed trauma victims.
The Future of Orphan Drugs: Advancements, Challenges and Hope
In the realm of healthcare and pharmaceuticals, orphan drugs have emerged as a beacon of hope for individuals suffering from rare diseases. With new technology and AI-driven analytics as drivers, these once-niche therapies are rapidly taking center stage.
Personalized Healthcare
Precise, personal treatment is the way of the future. Here’s how experts are using genetic sequencing to forge a revolutionary new way of practicing medicine.
New mRNA-Based Therapy Effective in Treating Melanoma in Mouse Models
Investigators at the Icahn School of Medicine at Mount Sinai have designed an RNA-based strategy to activate dendritic cells, which play a key role in immune response, that eradicated tumors and prevented their recurrence in mouse models of melanoma.
Combination of IVIG and Corticosteroids Superior to Respective Monotherapies for Treatment of Relapsed ITP in Adults
The combination of intravenous immune globulin (IVIG) and corticosteroids is a more efficient and rapid treatment for relapsed immune thrombocytopenic purpura (ITP) in adults compared with the use of either therapy alone.
Early Albumin Administration May Reduce Mortality in Septic Shock and ARDS: Retrospective MIMIC III Database Study
A study has found that early albumin administration in septic shock patients with ARDS was independently associated with a reduction in 28-day mortality.
Immunotherapy May Treat ALS, Says Study
A study led by scientists at Oregon Health & Science University has found that a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis (ALS).
Psychedelic Medicines: The Future?
Renewed interest and research in psychedelic compounds is giving formerly illicit drugs a 21st century image makeover. Are they really breakthrough solutions for treatment-resistant conditions such as depression and PTSD? At this point, the data looks promising.
Just Arrived: A Trio of Active and Passive Vaccines Against RSV
For decades, respiratory syncytial virus (RSV) has defied the best efforts of vaccine makers to bring it to heel, until now.
Study Finds Immunotherapy Causes Chronic Side Effects
A recent study has found chronic immune-related side effects are common in patients with skin cancer who are treated with postsurgical Opdivo (nivolumab) or Keytruda (pembrolizumab), although for some individuals, these toxicities resolve by the 18-month mark.
